Affinity-Asset-Advisors

AI_NATIVE detailed information: This accession holds the following tickers:[
  "MRUS",
  "NUVL",
  "AXSM",
  "EWTX",
  "TRVI",
  "CNTA",
  "ALKS",
  "INSM",
  "NAMS",
  "MDGL",
  "ALNY",
  "ABVX",
  "OLMA",
  "CATX",
  "MIRM",
  "THRD",
  "TVTX",
  "TRML",
  "NRIX",
  "MLYS",
  "KYMR",
  "ADGM",
  "AKBA",
  "ALLK",
  "AVTX",
  "AVR",
  "ESTA",
  "GERN",
  "GALT",
  "SYRE",
  "APGE",
  "AUTL",
  "NBIX",
  null,
  "LXEO",
  "MNPR",
  null,
  "NXTC",
  "NKTX",
  "OVID",
  "OKUR",
  "PRQR",
  "QTTB",
  "RPTX",
  "STRO",
  null,
  null,
  "RZLT",
  "EXEL",
  "TEVA",
  "IBRX",
  "ZURA",
  null,
  "SPY",
  null,
  null,
  "AMGN",
  null,
  null,
  null,
  "PTGX",
  "MBX",
  null,
  "SLNO",
  "ACLX",
  "QURE",
  "OMER",
  "ETNB",
  "WVE",
  "ROIV",
  null,
  "CNTX",
  "ERAS",
  "INZY",
  "VRNA",
  "VKTX",
  "VRDN",
  "XENE",
  "ORKA",
  "VERA",
  "IMVT",
  "PCVX",
  null,
  "BDTX",
  "BBIO",
  "CMPX",
  "CORT",
  "CRNX",
  "CGEM",
  "IWM",
  "MGTX"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-14
Total Holdings: 91
Total Value: 976714470
Accession Number: 0001999371-25-006074
Form Type: 13F-HR
CIK: affinity-asset-advisors
Manager Name: Affinity-Asset-Advisors

Data Enrichment

86% identified

78 identified13 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

91 positions • $976.7M total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 3 of 5

Sort by:

Autolus Therapeutics plc

AUTL|05280R100

Shares:3.0M

Value:$4.7M

% of Portfolio:0.5% ($4.7M/$976.7M)

Erasca, Inc.

ERAS|29479A108

Shares:3.3M

Value:$4.6M

% of Portfolio:0.5% ($4.6M/$976.7M)

Edgewise Therapeutics, Inc.

EWTX|28036F105

Shares:200.0K

Value:$4.4M

% of Portfolio:0.5% ($4.4M/$976.7M)

ProQR Therapeutics N.V.

PRQR|N71542109

Shares:3.3M

Value:$4.4M

% of Portfolio:0.4% ($4.4M/$976.7M)

uniQure N.V.

QURE|N90064101

Shares:400.0K

Value:$4.2M

% of Portfolio:0.4% ($4.2M/$976.7M)

G70077105

Shares:350.0K

Value:$3.6M

% of Portfolio:0.4% ($3.6M/$976.7M)

SOLENO THERAPEUTICS INC

SLNO|834203309

Shares:50.0K

Value:$3.6M

% of Portfolio:0.4% ($3.6M/$976.7M)

Inozyme Pharma, Inc.

INZY|45790W108

Shares:3.9M

Value:$3.5M

% of Portfolio:0.4% ($3.5M/$976.7M)

Mineralys Therapeutics, Inc.

MLYS|603170101

Shares:200.0K

Value:$3.2M

% of Portfolio:0.3% ($3.2M/$976.7M)

ImmunityBio, Inc.

IBRX|45256X103

Shares:1.0M

Value:$3.1M

% of Portfolio:0.3% ($3.1M/$976.7M)

Akebia Therapeutics, Inc.

AKBA|00972D105

Shares:1.5M

Value:$2.9M

% of Portfolio:0.3% ($2.9M/$976.7M)

578784100

Shares:250.0K

Value:$2.8M

% of Portfolio:0.3% ($2.8M/$976.7M)

N62509117

Shares:242.0K

Value:$2.7M

% of Portfolio:0.3% ($2.7M/$976.7M)

Kymera Therapeutics, Inc.

KYMR|501575104

Shares:100.0K

Value:$2.7M

% of Portfolio:0.3% ($2.7M/$976.7M)

G6717R120

Shares:250.0K

Value:$2.6M

% of Portfolio:0.3% ($2.6M/$976.7M)

Compass Therapeutics, Inc.

CMPX|20454B104

Shares:1.3M

Value:$2.5M

% of Portfolio:0.3% ($2.5M/$976.7M)

GERON CORP

GERN|374163103

Shares:1.5M

Value:$2.4M

% of Portfolio:0.2% ($2.4M/$976.7M)

Monopar Therapeutics

MNPR|61023L207

Shares:62.0K

Value:$2.3M

% of Portfolio:0.2% ($2.3M/$976.7M)

GALECTIN THERAPEUTICS INC

GALT|363225202

Shares:1.8M

Value:$2.2M

% of Portfolio:0.2% ($2.2M/$976.7M)

Mirum Pharmaceuticals, Inc.

MIRM|604749101

Shares:49.7K

Value:$2.2M

% of Portfolio:0.2% ($2.2M/$976.7M)

Instrument	Shares		Other Manager	Value	% of Portfolio
Autolus Therapeutics plc(AUTLcusip05280R100)	3.0M	QoQ -32.33% (-1.5M) YoY -9.77% (-330.0K)	All Managers (Combined)	$4.7M	0.5% ($4.7M/$976.7M)	QoQ -55.36% (-$5.9M) YoY -78.08% (-$16.8M)
Erasca, Inc.(ERAScusip29479A108)	3.3M	QoQ +33.69% (-842.1K) YoY NEW(+3.3M)	All Managers (Combined)	$4.6M	0.5% ($4.6M/$976.7M)	QoQ -27.02% (-$1.7M) YoY NEW(+$4.6M)
Edgewise Therapeutics, Inc.(EWTXcusip28036F105)	200.0K	QoQ NEW(+200.0K) YoY NEW(+200.0K)	All Managers (Combined)	$4.4M	0.5% ($4.4M/$976.7M)	QoQ NEW(+$4.4M) YoY NEW(+$4.4M)
ProQR Therapeutics N.V.(PRQRcusipN71542109)	3.3M	QoQ +16.26% (-459.5K) YoY NEW(+3.3M)	All Managers (Combined)	$4.4M	0.4% ($4.4M/$976.7M)	QoQ -41.64% (-$3.1M) YoY NEW(+$4.4M)
uniQure N.V.(QUREcusipN90064101)	400.0K	QoQ NEW(+400.0K) YoY NEW(+400.0K)	All Managers (Combined)	$4.2M	0.4% ($4.2M/$976.7M)	QoQ NEW(+$4.2M) YoY NEW(+$4.2M)
(cusipG70077105)✕	350.0K	QoQ 0.00% (+0) YoY NEW(+350.0K)	All Managers (Combined)	$3.6M	0.4% ($3.6M/$976.7M)	QoQ +1.57% (+$56.0K) YoY NEW(+$3.6M)
SOLENO THERAPEUTICS INC(SLNOcusip834203309)	50.0K	QoQ +24900.00% (+49.8K) YoY NEW(+50.0K)	All Managers (Combined)	$3.6M	0.4% ($3.6M/$976.7M)	QoQ +39638.59% (+$3.6M) YoY NEW(+$3.6M)
Inozyme Pharma, Inc.(INZYcusip45790W108)	3.9M	QoQ -2.63% (-104.6K) YoY +46.36% (-1.2M)	All Managers (Combined)	$3.5M	0.4% ($3.5M/$976.7M)	QoQ -68.01% (-$7.5M) YoY -82.61% (-$16.7M)
Mineralys Therapeutics, Inc.(MLYScusip603170101)	200.0K	QoQ -42.85% (-150.0K) YoY -39.01% (-128.0K)	All Managers (Combined)	$3.2M	0.3% ($3.2M/$976.7M)	QoQ -26.28% (-$1.1M) YoY -24.98% (-$1.1M)
ImmunityBio, Inc.(IBRXcusip45256X103)	1.0M	QoQ +310.00% (+775.0K) YoY +73.90% (-435.6K)	All Managers (Combined)	$3.1M	0.3% ($3.1M/$976.7M)	QoQ +382.07% (+$2.4M) YoY -2.52% (-$79.8K)
Akebia Therapeutics, Inc.(AKBAcusip00972D105)	1.5M	QoQ NEW(+1.5M) YoY NEW(+1.5M)	All Managers (Combined)	$2.9M	0.3% ($2.9M/$976.7M)	QoQ NEW(+$2.9M) YoY NEW(+$2.9M)
(cusip578784100)✕	250.0K	QoQ NEW(+250.0K) YoY NEW(+250.0K)	All Managers (Combined)	$2.8M	0.3% ($2.8M/$976.7M)	QoQ NEW(+$2.8M) YoY NEW(+$2.8M)
(cusipN62509117)✕	242.0K	QoQ +1.69% (-4.0K) YoY +19.42% (+39.4K)	All Managers (Combined)	$2.7M	0.3% ($2.7M/$976.7M)	QoQ -17.55% (-$584.9K) YoY +22.78% (+$509.5K)
Kymera Therapeutics, Inc.(KYMRcusip501575104)	100.0K	QoQ +150.00% (+60.0K) YoY NEW(+100.0K)	All Managers (Combined)	$2.7M	0.3% ($2.7M/$976.7M)	QoQ +70.08% (+$1.1M) YoY NEW(+$2.7M)
(cusipG6717R120)✕	250.0K	QoQ 0.00% (+0) YoY NEW(+250.0K)	All Managers (Combined)	$2.6M	0.3% ($2.6M/$976.7M)	QoQ +2.26% (+$57.5K) YoY NEW(+$2.6M)
Compass Therapeutics, Inc.(CMPXcusip20454B104)	1.3M	QoQ NEW(+1.3M) YoY NEW(+1.3M)	All Managers (Combined)	$2.5M	0.3% ($2.5M/$976.7M)	QoQ NEW(+$2.5M) YoY NEW(+$2.5M)
GERON CORP(GERNcusip374163103)	1.5M	QoQ -33.33% (-750.0K) YoY -40.00% (-1.0M)	All Managers (Combined)	$2.4M	0.2% ($2.4M/$976.7M)	QoQ -70.05% (-$5.6M) YoY -71.09% (-$5.9M)
Monopar Therapeutics(MNPRcusip61023L207)	62.0K	QoQ NEW(+62.0K) YoY NEW(+62.0K)	All Managers (Combined)	$2.3M	0.2% ($2.3M/$976.7M)	QoQ NEW(+$2.3M) YoY NEW(+$2.3M)
GALECTIN THERAPEUTICS INC(GALTcusip363225202)	1.8M	QoQ -26.31% (-655.8K) YoY NEW(+1.8M)	All Managers (Combined)	$2.2M	0.2% ($2.2M/$976.7M)	QoQ -30.31% (-$974.5K) YoY NEW(+$2.2M)
Mirum Pharmaceuticals, Inc.(MIRMcusip604749101)	49.7K	QoQ -29.75% (-21.1K) YoY -68.94% (-110.3K)	All Managers (Combined)	$2.2M	0.2% ($2.2M/$976.7M)	QoQ -23.47% (-$686.6K) YoY -44.30% (-$1.8M)